Table of Contents
PART 1: U.S. Cord Blood Banking Industry - Market Overview & Outlook
Stem cells derived from umbilical blood have been used in more than 30,000 transplants worldwide to treat a wide range of blood diseases, genetic and metabolic disorders, immunodeficiencies and various forms of cancer. Additionally, cord blood banks now exist in nearly every developed country, as well as several developing nations. However, there is still significant variation within the industry.
First, there is the divide between private and public cord blood banking, in which private companies serve individual families, while public banks serve the broader public. Additionally, some cord blood banks receive only units from nearby hospitals and birthing centers, while others allow mail-in units from a wide geographic region. There is also variation in the services offered by private cord blood banks, with cord tissue storage emerging as a commercial service in 2010, when the Cord Blood Registry began offering it, to complement its cord blood banking services. This trend of cord tissue storage has had a significant impact on the cord blood banking industry, with nine private U.S. companies now offering the service. Finally, there is also significant variation in the quality, pricing, and guarantees promised by U.S. cord blood banks.
This section of the report considers the impact of historical events, the importance of key findings and discoveries on market conditions, and rapidly changing aspects of the industry. It is a roadmap of where the cord blood banking industry has been, what has shaped it, and where it is going. With an understanding of these market conditions, the subsequent sections of this report become “rooted” and relevant.
PART 2: Expansion & Growth – Trailing 12-Month Analysis and Future Projections
While the last section “rooted” where the cord blood banking industry has been and what has shaped it, this section explores where it is now and what you can anticipate for the near-term future. It provides a detailed assessment of current market conditions and near-term projections.
This section is dedicated to revealing, quantifying, and extrapolating industry trends, for the purpose of giving meaningful projections for the future. It is your guide to understanding expansion and growth within the U.S. cord blood banking industry.B60
PART 3: Parent Survey – Continuing to Grow by Listening to Expectant Parents
To recap, the first section of the report “roots” where the cord blood banking industry has been and what has shaped it. The second section explores where it is now and what you should anticipate for the near-term future, and provides a detailed assessment of current market conditions and near-term projections. Most importantly, the previous section shows you what to expect if trends continue as they are; it reveals the environment that you will find yourself in if you don’t take strategic action.
This final section of the report is now your roadmap to the future. It is your guide to taking strategic action and controlling your competitive position as a U.S. cord blood bank.
This section contains findings from a detailed parent survey that reveal how expectant parents within the United States learn about cord blood banking, think about the process, and make key decisions. This survey is your insight into the minds of your prospective clients. Use it to claim powerful control over your ability to sell your services more effectively.
You can use the findings revealed here to:
• Alter the way you position your products
• Understand why parents bank publicly, privately, or not at all
• Communicate successfully with parents
• Effectively educate parents
• Prioritize your advertising budget
• Sell your services more effectively
In summary, this section is your guide to growing, expanding, and profiting, by listening to the needs of your clients – expectant parents.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
The blood screening market is expected to reach USD 2.80 billion by 2021 from USD 1.76 billion in 2016, at a CAGR of 9.7%. The global blood screening market is categorized based on technology, product ...
The global apheresis market is projected to reach USD 2.06 billion by 2021, at a CAGR of 7.7% during the forecast period of 2016 to 2021. Growth in this market is majorly driven by the rising prevalence ...
Blood collection, processing, management devices & consumables are class of medical devices used for collecting the whole blood from the donor, segregating the collected blood into blood components like ...